Hartmann M - Search Results

1

Pantoprazole does not interact with the pharmacokinetics of carbamazepine.

Huber R, Bliesath H, Hartmann M, Steinijans VW, Koch H, Mascher H, Wurst W. Huber R, et al. Among authors: hartmann m. Int J Clin Pharmacol Ther. 1998 Oct;36(10):521-4. Int J Clin Pharmacol Ther. 1998. PMID: 9799054 Clinical Trial.

2

Pharmacokinetics of teduglutide in subjects with renal impairment.

Nave R, Halabi A, Herzog R, Schaffer P, Diefenbach J, Krause S, Berghöfer P, Lahu G, Hartmann M. Nave R, et al. Among authors: hartmann m. Eur J Clin Pharmacol. 2013 May;69(5):1149-55. doi: 10.1007/s00228-012-1455-7. Epub 2012 Nov 28. Eur J Clin Pharmacol. 2013. PMID: 23187965 Clinical Trial.

3

A Thorough QT Study of Teduglutide in Healthy Subjects.

Hartmann M, Timmer W, Schultz A, Nave R, Luehmann R, Krause S, Lahu G, Scholpp J. Hartmann M, et al. Clin Pharmacol Drug Dev. 2012 Apr;1(2):57-66. doi: 10.1177/2160763X12438745. Clin Pharmacol Drug Dev. 2012. PMID: 27121220

4

Pharmacokinetics of pantoprazole in man.

Huber R, Hartmann M, Bliesath H, Lühmann R, Steinijans VW, Zech K. Huber R, et al. Among authors: hartmann m. Int J Clin Pharmacol Ther. 1996 May;34(5):185-94. Int J Clin Pharmacol Ther. 1996. PMID: 8738854 Clinical Trial.

5

Pharmacokinetics of pantoprazole in patients with end-stage renal failure.

Kliem V, Bahlmann J, Hartmann M, Huber R, Lühmann R, Wurst W. Kliem V, et al. Among authors: hartmann m. Nephrol Dial Transplant. 1998 May;13(5):1189-93. doi: 10.1093/ndt/13.5.1189. Nephrol Dial Transplant. 1998. PMID: 9623552

6

Pantoprazole and 24-hour intragastric acidity.

Hartmann M, Bliesath H, Lühmann R, Wurst W. Hartmann M, et al. Aliment Pharmacol Ther. 1993 Feb;7(1):115-6. doi: 10.1111/j.1365-2036.1993.tb00077.x. Aliment Pharmacol Ther. 1993. PMID: 8439633 Clinical Trial. No abstract available.

7

Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.

Simon B, Müller P, Bliesath H, Lühmann R, Hartmann M, Huber R, Wurst W. Simon B, et al. Among authors: hartmann m. Aliment Pharmacol Ther. 1990 Jun;4(3):239-45. doi: 10.1111/j.1365-2036.1990.tb00468.x. Aliment Pharmacol Ther. 1990. PMID: 1966542

8

Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.

Simon B, Müller P, Hartmann M, Bliesath H, Lühmann R, Huber R, Bohnenkamp W, Wurst W. Simon B, et al. Among authors: hartmann m. Z Gastroenterol. 1990 Sep;28(9):443-7. Z Gastroenterol. 1990. PMID: 2177296

9

Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.

Martínek J, Blum AL, Stolte M, Hartmann M, Verdú EF, Lühmann R, Dorta G, Wiesel P. Martínek J, et al. Among authors: hartmann m. Aliment Pharmacol Ther. 1999 Jan;13(1):27-34. doi: 10.1046/j.1365-2036.1999.00440.x. Aliment Pharmacol Ther. 1999. PMID: 9892876 Clinical Trial.

10

Current status of acid pump antagonists (reversible PPIs).

Wurst W, Hartmann M. Wurst W, et al. Among authors: hartmann m. Yale J Biol Med. 1996 May-Jun;69(3):233-43. Yale J Biol Med. 1996. PMID: 9165692 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results